| Serial Number | 79288877 |
| Word Mark | RADMAB |
| Filing Date | Monday, March 2, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 26, 2021 |
| Registration Number | 6253802 |
| Registration Date | Tuesday, January 26, 2021 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 10, 2020 |
| Goods and Services | Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer; diagnostic kits comprising medical diagnostic radiopharmaceutical reagents and assays for testing of bodily fluids and tissue for use in detecting cancer and also consisting of vials, needleless drug delivery devices, swabable vial adaptors and medical syringes; all of the foregoing containing monoclonal antibodies |
| Goods and Services | Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices for diagnostic radiopharmaceuticals; medical device for treating cancer; diagnostic imaging apparatus for medical use; applicators for pharmaceutical preparations, namely, drug delivery devices sold empty being syringes, infusion sets and catheters |
| Goods and Services | Scientific research; scientific research in the field of pharmacy; research on the subject of pharmaceuticals; medical research; research and development of products; providing scientific advisory services relating to immunological products; provision of scientific information in the fields of biochemistry, biotechnology and clinical trials; scientific consultancy, namely, consulting services in the fields of biotechnology, pharmaceutical research and development, and genetic science all of the aforementioned in relation to radiopharmaceuticals and cancer |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 17, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 17, 2020 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 17, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Telix Pharmaceuticals Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | AU |
| Party Name | Telix Pharmaceuticals Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | AU |
| Party Name | Telix Pharmaceuticals Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | AU |
| Event Date | Event Description |
| Sunday, August 14, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Sunday, May 23, 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, April 30, 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, April 30, 2021 | FINAL DISPOSITION PROCESSED |
| Monday, April 26, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, January 26, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, November 10, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 10, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 21, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, October 1, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sunday, September 27, 2020 | REFUSAL PROCESSED BY IB |
| Tuesday, September 22, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 21, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 21, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, September 5, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, August 27, 2020 | REFUSAL PROCESSED BY MPU |
| Friday, July 24, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, July 23, 2020 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 21, 2020 | APPLICATION FILING RECEIPT MAILED |
| Friday, July 17, 2020 | ASSIGNED TO EXAMINER |
| Friday, July 17, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Wednesday, July 15, 2020 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, July 2, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |